Literature DB >> 2073129

Toxicokinetics of N-nitrosodimethylamine in the Syrian golden hamster.

A J Streeter1, R W Nims, P P Wu, D L Logsdon.   

Abstract

The single-dose toxicokinetics of N-nitrosodimethylamine (NDMA) has been characterized in 8-week-old male Syrian golden hamsters by analysis using high performance liquid chromatography of serial blood samples. An i.v. bolus dose of 4.2 mumols/kg [14C]NDMA revealed biphasic first-order elimination with a terminal half-life of 8.7 +/- 1.0 min (mean +/- SE) for unchanged NDMA and 31.5 +/- 5.5 min for total radioactivity, and evidence for conversion to polar metabolites was seen in the chromatographic assays. The systemic blood clearance and apparent steady-state volume of distribution for unchanged NDMA were 51.2 +/- 3.0 ml/min/kg and 582 +/- 60 ml/kg, respectively. No unchanged NDMA was detected in the urine following an i.v. bolus dose of 15 mumols/kg [14C]NDMA, but 31% of the total radioactivity was eliminated by that route. A dose of 38 mumols/kg given by gavage indicated a systemic bioavailability of 11 +/- 4% for unchanged NDMA. Reversible binding of NDMA to hamster plasma proteins was found to be negligible. Estimation of the intrinsic hepatic clearance (ClI) in the hamster produced a value of 648 ml/min/kg, which is greater than that previously obtained for the rat, and indicates that the metabolic capacity of the hamster liver is greater than that of the rat. These results suggest that this difference in ClI may play a role in the previously reported (Lijinsky et al. 1987) switch in organotropism from almost exclusivity for liver tumors in hamsters dosed by gavage to additional high incidences of lung and kidney tumors in the rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073129     DOI: 10.1007/BF01971835

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  24 in total

1.  Toxic liver injury; the metabolism of dimethylnitrosamine.

Authors:  P N MAGEE
Journal:  Biochem J       Date:  1956-12       Impact factor: 3.857

2.  The decomposition and toxicity of dialkylnitrosamines in rats.

Authors:  D F Heath
Journal:  Biochem J       Date:  1962-10       Impact factor: 3.857

3.  Dietary effects on the pharmacokinetics of three carcinogenic nitrosamines.

Authors:  J S Wishnok; A E Rogers; O Sanchez; M C Archer
Journal:  Toxicol Appl Pharmacol       Date:  1978-02       Impact factor: 4.219

4.  Alkylation of nucleic acids and metabolism of small doses of dimethylnitrosamine in the rat.

Authors:  A E Pegg; W Perry
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

5.  Biological activity of N-nitrosodiethanolamine and of potential metabolites which may arise after activation by alcohol dehydrogenase in Salmonella typhimurium, in mammalian cells, and in vivo.

Authors:  E Denkel; B L Pool; J R Schlehofer; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  Low-dose in vivo pharmacokinetic and deuterium isotope effect studies of N-nitrosodimethylamine in rats.

Authors:  B A Mico; J E Swagzdis; H S Hu; L K Keefer; N F Oldfield; W A Garland
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Metabolism and activation of N-nitrosodimethylamine by hamster and rat microsomes: comparative study with weanling and adult animals.

Authors:  J S Yoo; S M Ning; C J Patten; C S Yang
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

8.  An examination of human blood for the presence of volatile nitrosamines.

Authors:  T A Gough; K S Webb; P F Swann
Journal:  Food Chem Toxicol       Date:  1983-04       Impact factor: 6.023

9.  Carcinogenesis by nitrosodialkylamines and azoxyalkanes given by gavage to rats and hamsters.

Authors:  W Lijinsky; R M Kovatch; C W Riggs
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

10.  Urinary excretion of nitrosodimethylamine and nitrosoproline in humans: interindividual and intraindividual differences and the effect of administered ascorbic acid and alpha-tocopherol.

Authors:  W A Garland; W Kuenzig; F Rubio; H Kornychuk; E P Norkus; A H Conney
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.